Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

Conditions:   Chronic Myeloid Leukemia, Chronic Phase;   Adult CML;   Leukemia, Myeloid;   Leukemia,Myeloid, Chronic Interventions:   Drug: Asciminib;   Drug: Ascimininb + Nilotinib Sponsors:   Augusta University;   H. Jean Khoury Cure CML Consortium Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials